Artificial intelligence

Over the last few years ContextVision has made significant investments in artificial intelligence technology. Today we have a R&D team with extensive experience and knowledge in this area.

Today we train machines to recognize objects (in this case, faces) by feeding a range of images into a deep network, which then predicts an output (in this case, a name). The output of the network is compared with the correct answer and a feedback signal updates the weights in the network until predictions are sufficiently correct.

Train and Treat: Cognitive Machines for Medicine
See the TEDx-talk with ContextVision’s Armando Vieira & Martin Hedlund, founder

Second place in the international competition “Camelyon Challenge”

Our deep learning skills were proven in an international competition in October 2016, when our team won second and third place in four different categories.
Grand Challenge TUPAC 16 (TUmour Proliferation Assessment Challenge) finds mitoses in breast tissue and predicts the proliferation score (which relates to aggressiveness of the cancer)
True and false positive mitoses are often hard to separate.
Real time 3D (“4D”) enhanced ultrasound “smiling” fetus, and a photo of the same “smiling” baby after birth.
ContextVision’s own history allows us to take such a leap into deep learning. Our GOP technology – used within the company for over 30 years – has many similarities to neural networks, as it is also inspired by the human visual system. Networks of convolutions are included in many of our products for 2D/3D/4D enhancement today. The learning parts of these networks (i.e. artificial intelligence) are new. ContextVision has also established processes for effective product development and implementations on different platforms, and has extensive knowledge in these areas.
With the new AI technology, we can develop machines to help humans, resulting in better treatment and more effective healthcare.

Read the Q&A with Martin Hedlund, CTO

Read the Q&A with Martin Hedlund, CTO